| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kate McKeage, Greg L Ploske. Amisulpride: a review of its use in the management of schizophrenia. CNS drugs. vol 18. issue 13. 2005-02-04. PMID:15521794. |
thus, amisulpride is an effective and well tolerated option for the first-line treatment of patients with acute schizophrenia as well as for those requiring long-term maintenance therapy. |
2005-02-04 |
2023-08-12 |
Not clear |
| J Munro, P Matthiasson, S Osborne, M Travis, S Purcell, A M Cobb, M Launer, M D Beer, R Kerwi. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta psychiatrica Scandinavica. vol 110. issue 4. 2005-01-11. PMID:15352931. |
amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. |
2005-01-11 |
2023-08-12 |
Not clear |
| S L Barrett, R Bell, D Watson, D J Kin. Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers. Journal of psychopharmacology (Oxford, England). vol 18. issue 2. 2004-10-08. PMID:15260903. |
furthermore, as the trend for disrupted visual latent inhibition following amisulpride was similar in nature to that which would be expected with amphetamine, it was concluded that its behaviour in this model is consistent with its preferential presynaptic dopamine antagonistic activity in low dose and its efficacy in the negative symptoms of schizophrenia. |
2004-10-08 |
2023-08-12 |
human |
| Giorgio Racagni, Pier Luigi Canonico, Luigi Ravizza, Luca Pani, Mario Amor. Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology. vol 50. issue 2. 2004-08-31. PMID:15292667. |
in the present review, the clinical use of amisulpride in depressive syndromes is discussed, in particular in dysthymia and in schizophrenia. |
2004-08-31 |
2023-08-12 |
Not clear |
| Giorgio Racagni, Pier Luigi Canonico, Luigi Ravizza, Luca Pani, Mario Amor. Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology. vol 50. issue 2. 2004-08-31. PMID:15292667. |
based on experimental data, amisulpride is a treatment of choice for dopaminergic transmission disorders, both in depression and in schizophrenia. |
2004-08-31 |
2023-08-12 |
Not clear |
| Mathias Zink, Udo Knopf, Fritz A Henn, Johannes Thom. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Pharmacopsychiatry. vol 37. issue 1. 2004-08-02. PMID:14750045. |
combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. |
2004-08-02 |
2023-08-12 |
Not clear |
| Małgorzata Rzewuska, Wojciech Kuczyński, Małgorzata Luk. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study]. Psychiatria polska. vol 38. issue 3. 2004-07-22. PMID:15199655. |
[effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study]. |
2004-07-22 |
2023-08-12 |
Not clear |
| Małgorzata Rzewuska, Wojciech Kuczyński, Małgorzata Luk. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study]. Psychiatria polska. vol 38. issue 3. 2004-07-22. PMID:15199655. |
6-month multicentre, observational, open study evaluated the efficacy and tolerability of the new generation antipsychotic drug amisulpride in patients with acute schizophrenia. |
2004-07-22 |
2023-08-12 |
Not clear |
| Philip J Tyson, Kate H Roberts, Ann M Mortime. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? The International journal of neuroscience. vol 114. issue 6. 2004-07-19. PMID:15204055. |
forty-four patients with a dsm-iv diagnosis of schizophrenia were recruited within 6 weeks of starting one of the atypical antipsychotics: clozapine, olanzapine, risperidone, quetiapine, or amisulpride. |
2004-07-19 |
2023-08-12 |
Not clear |
| Ann Mortimer, Stephen Martin, Henri Lôo, Joseph Peusken. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076013. |
a double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. |
2004-06-22 |
2023-08-12 |
Not clear |
| Ann Mortimer, Stephen Martin, Henri Lôo, Joseph Peusken. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076013. |
a multicentre, double-blind, randomized trial was performed to compare amisulpride and olanzapine in the treatment of acute schizophrenia. |
2004-06-22 |
2023-08-12 |
Not clear |
| Ann Mortimer, Stephen Martin, Henri Lôo, Joseph Peusken. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076013. |
the efficacy of amisulpride is not inferior to that of olanzapine in the treatment of acute schizophrenia. |
2004-06-22 |
2023-08-12 |
Not clear |
| N Bergemann, J Kopitz, K R Kress, A Fric. Plasma amisulpride levels in schizophrenia or schizoaffective disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 14. issue 3. 2004-06-21. PMID:15056484. |
plasma amisulpride levels in schizophrenia or schizoaffective disorder. |
2004-06-21 |
2023-08-12 |
Not clear |
| N Bergemann, J Kopitz, K R Kress, A Fric. Plasma amisulpride levels in schizophrenia or schizoaffective disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 14. issue 3. 2004-06-21. PMID:15056484. |
the plasma amisulpride levels of 85 patients with schizophrenia or schizoaffective disorder (mean age: 34.0+/-11.4 years; 40 women, 45 men) were assessed by high-performance liquid chromatography (hplc) with fluorometric detection. |
2004-06-21 |
2023-08-12 |
Not clear |
| Marcus W Agelink, Ilker Kavuk, Ismail A. Clozapine with amisulpride for refractory schizophrenia. The American journal of psychiatry. vol 161. issue 5. 2004-06-03. PMID:15121665. |
clozapine with amisulpride for refractory schizophrenia. |
2004-06-03 |
2023-08-12 |
Not clear |
| F Péhourcq, S Ouariki, B Bégau. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 789. issue 1. 2004-02-10. PMID:12726848. |
amisulpride, a substituted benzamide derivative, is a second-generation (atypical) antipsychotic and is effective as maintenance therapy in patients with schizophrenia. |
2004-02-10 |
2023-08-12 |
human |
| Kelly French, Diane Eastwoo. Response of catatonic schizophrenia to amisulpride: a case report. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 48. issue 8. 2004-01-29. PMID:14574833. |
response of catatonic schizophrenia to amisulpride: a case report. |
2004-01-29 |
2023-08-12 |
Not clear |
| Siegfried Kaspe. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia. International clinical psychopharmacology. vol 17 Suppl 4. 2003-05-02. PMID:12685918. |
dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia. |
2003-05-02 |
2023-08-12 |
human |
| Robin Emsley, Piet Oosthuize. The new and evolving pharmacotherapy of schizophrenia. The Psychiatric clinics of North America. vol 26. issue 1. 2003-05-01. PMID:12683264. |
atypical antipsychotics (except amisulpride) have shown superiority over placebo in acute schizophrenia. |
2003-05-01 |
2023-08-12 |
Not clear |
| Jitschak G Storosum, André J A Elferink, Barbara J van Zwieten, Roel van Strik, Witte J G Hoogendijk, André W Broekman. Amisulpride: is there a treatment for negative symptoms in schizophrenia patients? Schizophrenia bulletin. vol 28. issue 2. 2003-05-01. PMID:12693427. |
amisulpride: is there a treatment for negative symptoms in schizophrenia patients? |
2003-05-01 |
2023-08-12 |
Not clear |